We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cancer Diagnosis by Mass Spectroscopy

By Biotechdaily staff writers
Posted on 23 Nov 2005
Researchers have converted a mass spectrometer, a common instrument in analytic chemistry laboratories, for use in diagnosing cancer and monitoring tumor growth.

Investigators at Purdue University (West Lafayette, IN, USA) and Vanderbilt University (Nashville, TN, USA) developed an advanced sampling mechanism that enhanced a mass spectrometer used for electrospray ionization spectroscopy and turned it into a medical diagnostic tool.

In electrospray ionization, a liquid is pushed through a very small charged metal capillary by a carrier gas. More...
The liquid contains the substance that is to be studied, the analyte, as well as a large amount of solvent, which is usually much more volatile than the analyte. The charge contained in the capillary transfers to the liquid, which charges the analyte molecule. As like charges repel, the liquid pushes itself out of the capillary and forms an aerosol of small droplets about 10 µm across. A neutral carrier gas is sometimes used to evaporate the neutral solvent in the small droplets, which brings the charged analyte molecules closer together. The proximity of the molecules becomes unstable, however, and as the similarly charged molecules come closer together, the droplets explode. This process repeats itself until the analyte is free of solvent and is a lone ion. The lone ion then continues along to a mass analyzer.

The improved detector described in this study is a handheld wand that directs a fine water mist at a surface and then absorbs the fluid after the droplets have mixed with the material in the sample. Details were published in the November 4, 2005, issue of Angewandte Chemie.

With this method--nicknamed DESI (desorption electrospray ionization)--investigators were able to resolve chemical differences between sample areas as small as a half-millimeter. This level of resolution was sufficient to allow detection of very small tumors in a tissue sample. The technique could differentiate between diseased and non-diseased regions of tissue samples within a few seconds.

Senior author Dr. R. Graham Cooks, professor of analytic chemistry at Purdue University, said, "For now, we have shown that DESI can quickly provide medically relevant information to physicians, including the location of the boundary between cancerous and healthy tissue, accurate to within the diameter of just a few cells. That gives us cause for optimism.”




Related Links:
Purdue University
Vanderbilt University

New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Benchtop Thermomixer
Biometra TS1 ThermoShaker
New
HPV Molecular Test
BD Onclarity HPV Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.